Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Purdue Pharma
Purdue Pharma
Activities:
Ingredients
Dietary supplements
Active Nutrition
Food
Nutraceutical
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
Purdue Pharma sells North Carolina site to Novo Nordisk
The solid dose manufacturing site will be refurbished to manufacture tablets for oral semaglutide (diabetes treatment) and future oral medicines
Ingredients
Therapeutics: lemborexant for sleep disorders
About a third of adults suffer from the symptoms of insomnia, such as difficulty falling asleep, staying asleep or both
Finance
Purdue Pharma eyes bankruptcy amid opioid overdose crisis
The OxyContin maker faces thousands of lawsuits alleging the drugmaker contributed to the deadly opioid crisis in the United States
Research & Development
Mundipharma Laboratories and Purdue Pharma enter global partnership with Laboratorios Esteve
To drive innovation in pain management
Subscribe now